Kuros Biosciences AG: Kuros Biosciences announces favorable preliminary results of MagnetOs as standalone alternative to autograft in first randomized controlled trial

Kuros Biosciences AG / Key word(s): Miscellaneous Kuros Biosciences announces favorable preliminary results of MagnetOs as standalone alternative to autograft in first randomized controlled

Related Keywords

Zurich ,Züsz ,Switzerland ,California ,United States ,Netherlands ,Bahamas ,The ,San Francisco ,Swiss ,Kuros Biosciences ,Sigurd Berven ,Hans Herklots ,Michael Grau ,Van Dijk ,Phila Pa ,News Service ,Swiss Exchange ,Spine Service At University Of California ,Magnetos Granules ,Chief Executive Officer ,Project Fusion ,Professor Sigurd Berven ,Spine Service ,Annual Meeting ,International Society ,Spine Surgery ,Kuros ,Iosciences ,Nnounces ,Favorable ,Reliminary ,Results ,Magnetos ,Standalone ,Alternative ,Autograft ,First ,Randomized ,Ontrolled ,Trial ,